SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Home
Companies
SANOFI-AVENTIS

BRIEF

published on 12/19/2025 at 20:26, 1 month 19 days ago

Sanofi Agreement with US Government to Lower Medicine Costs

Innovation Healthcare Savings US Government Sanofi Agreement Medicine Costs
PRESS RELEASE

published on 12/19/2025 at 20:21, 1 month 19 days ago

Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
Sanofi agrees with US government to lower medicine costs, support innovation, and US manufacturing. Agreement meets President Trump's requests, ensuring affordable access for American patients

Innovation Manufacturing Sanofi US Government Medicine Costs
BRIEF

published on 12/17/2025 at 07:35, 1 month 21 days ago

Sanofi Releases Q4 2025 Aide Mémoire

Sanofi Financial Modeling Aide Mémoire Q4 2025 Forward-Looking
BRIEF

published on 12/17/2025 at 07:35, 1 month 21 days ago

Sanofi publishes the document "Q4 2025 Quick Reference Guide"

Financial Results Investors Sanofi Q4 2025 Modeling
PRESS RELEASE

published on 12/17/2025 at 07:30, 1 month 21 days ago

Press release: Availability of the Q4 2025 Aide memoire
Sanofi announces availability of Q4 2025 Aide memoire on the company's website for financial modeling purposes. Q4 2025 results to be published on January 29, 2026

Sanofi Results Aide Mémoire Financial Modelling Q4 2025
BRIEF

published on 12/15/2025 at 07:10, 1 month 23 days ago

Sanofi Halts Pursuit of Regulatory Registration for Tolebrutinib in PPMS

Multiple Sclerosis Tolebrutinib PPMS Trial PERSEUS Study Sanofi R&D
BRIEF

published on 12/15/2025 at 07:10, 1 month 23 days ago

Sanofi: PERSEUS study results on tolebrutinib disappointing

Study Results Multiple Sclerosis Sanofi Tolebrutinib PERSEUS Study
PRESS RELEASE

published on 12/15/2025 at 07:05, 1 month 23 days ago

Press Release: Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis
Sanofi updates on tolebrutinib in primary progressive multiple sclerosis, PERSEUS phase 3 study did not meet primary endpoint. Safety profile consistent. Financial impacts discussed

Sanofi Tolebrutinib Primary Progressive Multiple Sclerosis PERSEUS Phase 3 Study Financial Considerations
BRIEF

published on 12/15/2025 at 07:05, 1 month 23 days ago

Sanofi's Tolebrutinib Regulatory Submission Delayed

FDA Multiple Sclerosis Sanofi Tolebrutinib Regulatory Delay
PRESS RELEASE

published on 12/15/2025 at 07:00, 1 month 23 days ago

Press Release : Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Sanofi anticipates a delay in tolebrutinib regulatory decision for nrSPMS, with ongoing discussions with the FDA. An expanded access protocol has been submitted for eligible patients

FDA Sanofi Tolebrutinib Regulatory Submission NrSPMS

Accesswire

Published on 02/07/2026 at 01:00, 1 day 4 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 6 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 7 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 13 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 15 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 8 hours 27 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 12 hours 52 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 13 hours 7 minutes ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 10 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 11 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 11 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 13 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 19:24, 2 days 10 hours ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 18:24, 2 days 11 hours ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:06, 2 days 11 hours ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026

View all LES ECHOS COMFI WIRE